ANIP — ANI Pharmaceuticals Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousMid CapHigh Flyer

Annual balance sheet for ANI Pharmaceuticals, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Cash and Short Term Investments	62.3	7.86	100	48.2	221
Net Total Accounts Receivable
Net Total Receivables	73.2	95.8	132	169	162
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	188	170	322	344	520
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	40.6	41.3	52.7	43.2	44.6
Net Goodwill
Net Intangible Assets
Other Long Term Assets
Total Assets	457	461	772	760	904
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	61.7	78.6	87.5	99.4	145
Long Term Debt
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	244	265	413	422	447
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Other Equity
Total Equity	213	196	359	339	458
Total Liabilities & Shareholders' Equity	457	461	772	760	904
Total Common Shares Outstanding
Total Preferred Shares Outstanding